geniposide has been researched along with Liver Steatosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chae, HJ; Lee, GH; Lee, HY; Yoon, Y | 1 |
| Bian, YQ; Cao, HY; Dong, S; Li, JY; Liu, P; Sun, L; Sun, MY; Sun, RF; Wu, C | 1 |
| Huang, C; Li, J; Ma, T; Meng, X; Tang, W; Zha, D; Zong, G | 1 |
| Aburada, M; Ishizaki, J; Kojima, K; Miyamoto, K; Nagareda, Y; Sai, Y; Shimada, T; Watanabe, M | 1 |
1 review(s) available for geniposide and Liver Steatosis
| Article | Year |
|---|---|
Therapeutic mechanism of Yīn-Chén-Hāo decoction in hepatic diseases.
Topics: Animals; Anthraquinones; Anti-Inflammatory Agents; Antiviral Agents; Artemisia; Ascites; Chlorogenic Acid; Clinical Trials as Topic; Coumarins; Drugs, Chinese Herbal; Emodin; Fatty Liver; Gardenia; Humans; Iridoids; Liver Diseases; Plant Extracts; Rheum | 2017 |
3 other study(ies) available for geniposide and Liver Steatosis
| Article | Year |
|---|---|
Topics: AMP-Activated Protein Kinases; Animals; Antioxidants; Diet, High-Fat; Disease Models, Animal; Endoplasmic Reticulum Stress; Eucommiaceae; Fatty Liver; Iridoid Glucosides; Iridoids; Lipid Peroxidation; Male; Oxidative Stress; Phytotherapy; Plant Extracts; Rats, Sprague-Dawley; Reactive Oxygen Species | 2019 |
Hepatoprotective effects of geniposide in a rat model of nonalcoholic steatohepatitis.
Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents; Aspartate Aminotransferases; Cytochrome P-450 CYP2E1; Dietary Fats; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fatty Liver; Insulin; Iridoids; Lipid Metabolism; Male; Malondialdehyde; Non-alcoholic Fatty Liver Disease; PPAR alpha; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2011 |
Preventive effect of geniposide on metabolic disease status in spontaneously obese type 2 diabetic mice and free fatty acid-treated HepG2 cells.
Topics: Adipose Tissue; Animals; Anti-Obesity Agents; Body Weight; Diabetes Mellitus, Type 2; Drug Evaluation, Preclinical; Fatty Acids, Nonesterified; Fatty Liver; Gardenia; Glucose Intolerance; Hep G2 Cells; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Iridoids; Lipid Metabolism; Liver; Male; Metabolic Diseases; Metabolic Syndrome; Mice; Mice, Obese; Obesity; Phytotherapy; Plant Preparations | 2011 |